Vienna - Delayed Quote EUR
argenx SE (ARGX.VI)
530.20
+4.60
+(0.88%)
At close: 3:30:16 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-82,747
-82,747
-420,327
-862,807
-606,812
Investing Cash Flow
-717,594
-717,594
308,210
-461,184
-347,070
Financing Cash Flow
279,759
279,759
1,336,727
843,757
1,121,342
End Cash Position
1,499,936
1,499,936
2,048,844
800,740
1,334,676
Capital Expenditure
-68,301
-68,301
-43,812
-103,823
-121,434
Issuance of Capital Stock
--
--
1,196,731
760,953
1,091,326
Repayment of Debt
-7,638
-7,638
-3,801
-4,165
-3,855
Free Cash Flow
-151,048
-151,048
-464,139
-966,630
-728,246
12/31/2021 - 9/18/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
8E8.MU Elicera Therapeutics AB
0.3040
0.00%
PHM.VI Pharma Mar, S.A.
81.30
+1.82%
UNC.F UCB SA
146.20
+2.60%
CNTA Centessa Pharmaceuticals plc
13.61
+4.45%
UCB.BR UCB SA
147.35
+0.41%
ITOS iTeos Therapeutics, Inc.
7.46
+4.34%
ACLX Arcellx, Inc.
63.97
+0.53%
IOBT IO Biotech, Inc.
0.9228
-1.83%
ZNTL Zentalis Pharmaceuticals, Inc.
1.5100
+0.67%
CRNX Crinetics Pharmaceuticals, Inc.
33.39
+3.15%